This week, Lilly released positive results on weight loss from a phase 2 retatrutide trial
Microneedling punches temporary holes through the barrier
This work was supported by the Cangzhou Science and Technology Plan Self-financed Project (2023-202423244102075), the Military Key Discipline Construction Projects of China (HL21JD1206), and the National Natural Science Foundation of China (82401967)
Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism
Who Should Consider GLP-1 Therapy and the Role of Genetic Context GLP-1 therapy applies to adults with BMI 30 kg/m or 27 with weight-related conditions, or those with type 2 diabetes
HBOT has been clinically explored with conjunctive multiagent chemotherapy and radiotherapy for patients with high-grade gliomas (156, 163, 164)